D M Livermore

发表

Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.

M. Kaufmann, S. Gaskin, T. Pitt, 1996, Journal of medical microbiology.

Antibiotic resistance: location, location, location.

D. Livermore, A. Pearson, D M Livermore, 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Antibiotic resistance in staphylococci.

D. Livermore, D M Livermore, 2000, International journal of antimicrobial agents.

Quality of antimicrobial susceptibility testing in the UK: a Pseudomonas aeruginosa survey revisited.

D M Livermore, H Y Chen, 1999, The Journal of antimicrobial chemotherapy.

Acquired carbapenemases.

D. Livermore, D M Livermore, 1997, The Journal of antimicrobial chemotherapy.

Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae.

D. Livermore, D M Livermore, L. Hall, 1998, The Journal of antimicrobial chemotherapy.

Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance

D. Livermore, H. Nikaido, X. Li, 1994, Antimicrobial Agents and Chemotherapy.

Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test.

D. Livermore, D. James, M. Warner, 2001, The Journal of antimicrobial chemotherapy.

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis

R C George, D. Livermore, R. George, 2000, BMJ : British Medical Journal.

Are all beta-lactams created equal?

D. Livermore, D M Livermore, 1996, Scandinavian journal of infectious diseases. Supplementum.

Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in Escherichia coli with CTX-M phenotypes.

D M Livermore, H Donaldson, M McCalmont, 2008, The Journal of antimicrobial chemotherapy.

Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae.

D. Livermore, E. Fagan, M. Warner, 2006, The Journal of antimicrobial chemotherapy.

Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.

D. Livermore, D M Livermore, M. Yuan, 1996, The Journal of antimicrobial chemotherapy.

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.

N Woodford, R Canton, A. Friedrich, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa.

D. Livermore, D M Livermore, H Y Chen, 1995, The Journal of antimicrobial chemotherapy.

Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests.

H Mittermayer, R Canton, F. Baquero, 2002, The Journal of antimicrobial chemotherapy.

Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin

D. Livermore, H. Nikaido, X. Li, 1994, Antimicrobial Agents and Chemotherapy.

Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.

N Woodford, N. Woodford, D. Livermore, 2011, The Journal of antimicrobial chemotherapy.

Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes.

D. Livermore, T. Winstanley, D M Livermore, 2001, The Journal of antimicrobial chemotherapy.

Worldwide emergence of carbapenem-resistant Acinetobacter spp.

D. Livermore, M. Afzal-Shah, D M Livermore, 1998, The Journal of antimicrobial chemotherapy.

Beta-lactamase-mediated resistance and opportunities for its control.

D. Livermore, D M Livermore, 1998, The Journal of antimicrobial chemotherapy.